Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Nuedexta for the Treatment of Pseudobulbar Affect (PBA)

Drug Name (Brand / Generic)

Nuedexta / dextromethorphan hydrobromide, quinidine sulfate

Developed By

Avanir Pharmaceuticals

Product Description

Combination drug

Current Indication

Pseudobulbar Affect (PBA)

Market Sector

CNS

Development Status

Approved in the US, European Union, Iceland and Norway
Expand
Close
Close
Close

Go Top